Shimokawa H, Miura M, Nochioka K, Sakata Y (2015) Heart failure as a general pandemic in Asia. Eur J Heart Fail 17:884–892

Article  PubMed  Google Scholar 

Tsutamoto T, Wada A, Maeda K (2001) Effects of spilonolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure. J Am Coll Cardiol 37:1228–1233

Article  CAS  PubMed  Google Scholar 

Tsutamoto T, Wada A, Maeda K, Hisanaga T, Mabuchi N, Hayashi M, Ohnishi M, Sawaki M, Fujii M, Horie H, Sugimoto Y, Kinoshita M (1999) Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Eur Heart J 20:1799–1807

Article  CAS  PubMed  Google Scholar 

Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297

Article  CAS  PubMed  Google Scholar 

Ambros V (2004) The functions of animal microRNAs. Nature 431:350–355

Article  CAS  PubMed  Google Scholar 

Zou Y, Yin J, Zhang Q (2023) MIR-568 mitigated cardiomyocytes apoptosis, oxidative stress response and cardiac dysfunction via targeting SMURF2 in heart failure rats. Heart Vessels 38:857–868

Article  PubMed  Google Scholar 

Yang W, Han Y, Yang C, Chen Y, Zhao W, Su X, Yang K, Jin W (2019) MicroRNA-19b-1 reverses ischaemia-induced heart failure by inhibiting cardiomyocyte apoptosis and targeting Bcl2 I11/BIM. Heart Vessels 34:1221–1229

Article  PubMed  Google Scholar 

Cordes KR, Sheehy NT, White M, Berry E, Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN, Srivastava D (2009) miR-145 and miR-143 regulate smooth muscle cell fate decisions. Nature 460:705–710

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sala F, Aranda JF, Rotllan N, Ramírez CM, Aryal B, Elia L, Condrelli G, Catapano AL, Fernandez-Hernando C, Norata GD (2014) MiR-143/145 deficiency attenuates the progression of atherosclerosis in Ldlr-/-mice. Thromb Haemost 112:796–802

Article  PubMed  PubMed Central  Google Scholar 

Deacon DC, Nevis KR, Cashman TJ, Xhou Y, Zhao L, Washko D, Guner-Ataman B, Burns CG, Burns CE (2010) The miR-143-adducin3 pathway is essential for cardiac chamber morphogenesis. Development 137:1887–1896

Article  CAS  PubMed  Google Scholar 

Li R, Yan G, Zhang Q, Jiang Y, Sun H, Hu Y, Sun J, Xu B (2013) miR-145 inhibits isoproterenol-induced cardiomyocyte hypertrophy by targeting the expression and localization of GATA 6. FEBS Lett 587:1754–1761

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao W, Zhao SP, Zhao YH (2015) MicroRNA-143/-145 in cardiovascular diseases. Biomed Res Int 2015:531740

Article  PubMed  PubMed Central  Google Scholar 

Higashi K, Yamada Y, Minatoguchi S, Baba S, Iwasa M, Kanamori H, Kawasaki M, Nishigaki K, Takemura G, Kumazaki M, Akao Y, Minatoguchi S (2015) MicroRNA-145 repairs infarcted myocardium by accelerating cardiomyocyte. Autophagy. Am J Physiol Heart Circ Physiol 309:H1813–H1826

Article  CAS  PubMed  Google Scholar 

Satake A, Minatoguchi S, Heishima K, Yasuda S, Murase H, Yoshizumi R, Komaki M, Baba S, Ojio S, Tanaka T, Akao Y, Minatoguchi S, Okura H (2023) An increase in plasma micro RNA-143 in the acute phase is positively correlated with recovery of cardiac function in the chronic phase in patients with acute myocardial infarction. Circ J 87:824–833

Article  CAS  PubMed  Google Scholar 

Akao Y, Naoe T, Hirata I, Nakagawa Y, Iio A (2010) Identification of non-coding RNAs embracing microRNA-143/145 cluster. Mol Cancer 9:136

Article  PubMed  PubMed Central  Google Scholar 

Fukada M, Matsuhashi N, Takahashi T, Sugito N, Heishima K, Yoshida K, Akao Y (2021) Postoperative changes in plasma miR21-5p as a novel biomarker for colorectal cancer recurrence: a prospective study. Cancer Sci 112:4270–4280

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heishima K, Mori T, Ichikawa Y, Sakai H, Kuranaga Y, Nakagawa T, Tanaka Y, Okamura Y, Masuzawa M, Sugito N, Murakami M, Yamada N, Akao Y, Maruo K (2015) MicroRNA-214 and microRNA-126 are potential biomarkers for malignant endothelial proliferative diseases. Int J Mol Sci 16:25377–25391

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhelankin AV, Vasiliev SV, Stonogina DA, Babalyan KA, Sharova EI, Doludin YV, Shchekochikhin DY, Generozov EV, Akselrod AS (2020) Elevated plasma levels of circulating extracellular miR-320a-3p in patients with paroxysmal atrial fibrillation. Int J Med Sci 21:3485

CAS  Google Scholar 

Yamano T, Kubo S, Sonoda E, Kominato T, Kimura K, Yasuhara M, Kataoka K, Son J, Babaya A, Takenaka Y, Matsubara T, Beppu N, Ikeda M (2021) Assessment of circulating microRNA specific for patients with familial adenomatous polyposis. PLoS ONE 16:e0250072

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boettger T, Beetz N, Kostin S, Schneider J, Kruger M, Hein L, Braun T (2009) Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J Clin Invest 119:2634–2647

Article  CAS  PubMed  PubMed Central  Google Scholar 

Norata GD, Pinna C, Zappella F, Elia L, Sala A (2012) Condorelli G、Catapano AL (2012) MicroRNA 143–145 deficiency impairs vascular function. Int J Immunopathol Pharmacol 25:467–474

Article  CAS  PubMed  Google Scholar 

Hergenreider E, Heydt S, Treguer K, Boettger T, Horrevoets AJG, Zeiher AM, Scheffer MP, Frangakis AS, Yin X, Mayr M, Braun T, Urbich C, Boon RA (2012) Dimmeler S (2012) Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 14:249–256

Article  CAS  PubMed  Google Scholar 

Boettger T, Beetz N, Kostin S, Schneider J, Kruger M, Hein L, Braun T (2009) Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J Clin Invest 119:2634–2647

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fichtcherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Röxe T, Müller-Ardogan M, Bonauer A, Zeiher AM, Dimmeler S (2010) Circulating microRNAs in patients with coronary artery disease. Circ Res 107:677–684

Article  Google Scholar 

Santovito D, Mandolini C, Marcantonio P, De Nardis V, Bucci M, Paganelli C, Magnacca F, Ucchino S, Mastroiacovo D, Desideri G, Mezzetti A, Cipollone F (2013) Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients. Expert Opin Ther Targets 17:217–223

Article  CAS  PubMed  Google Scholar 

Elia L, Quintavalle M, Zhang J, Contu R, Cossu L, Latronico MVG, Peterson KL, Indolfi C, Catalucci D, Chen J, Courtneidge SA, Condorelli G (2009) The knockout of miR-143 and -145 alters smooth muscle muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ 16:1590–1598

Article  CAS  PubMed  Google Scholar 

Geekiyanagea H, Rayatpishehb S, Wohlschlegelb JA, Brown Jrc R, Ambrosa V (2020) Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides. Proc Natl Acad Sci USA 117:24213–24223

Article  Google Scholar 

Ribeiro-Rodrigues TM, Laundos TL, Pereira-Carvalho R, Batista-Almeida D, Pereira R, Coelho-Santos V, Silva AP, Fernandes R, Zurarte M, Enguita FJ, Costa MC, Pinto-do-O P, Pinto M, Gouveia P, Ferreira L, Mason JC, Pereira P, Kwak BR, Nascimento DS, Girao H (2017) Exosomes secreted by cardiomyocytes subjected to ischaemia promote cardiac angiogenesis. Cardiovasc Res 113:1338–1350

Article  CAS  PubMed  Google Scholar 

Zhao W, Zhao SP, Zhao YH (2015) MicroRNA-143/-145 in cardiovascular diseases. BioMed Res Int. https://doi.org/10.1155/2015/531740

Article  PubMed  PubMed Central  Google Scholar 

Mohl W, Spitzer E, Mader RM, Wagh V, Nguemo F, Milasinovic D, Jusic A, Khazen C, Szodorai E, Birkenberg B, Lubec G, Hescheler J, Serruys PW (2018) Acute molecular effects of pressure-controlled intermittent coronary sinus occlusion in patients with advanced heart failure. ESC Heart Fail 5:1176–1183

Article  PubMed  PubMed Central  Google Scholar 

Bhat PK, Ashwath ML, Rosenbaum DS, Costantini O (2012) Usefulness of left ventricular end-systolic dimension by echocardiography to predict reverse remodeling in patients with newly diagnosed severe left ventricular systolic dysfunction. Am J Cardiol 110:83–87

Article  PubMed  Google Scholar 

Moilanen AM, Rysa J, Mustonen E, Serpi R, Aro J, Tokola H, Leskinen H, Manninen A, Levijoki J, Vuolteenaho O, Ruskoaho H (2011) Intramyocardial BNP gene delivery improves cardiac function through distinct context-dependent mechanisms. Circ Heart Fail 4:483–495

Article  CAS  PubMed  Google Scholar 

McMurray JJV, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, PARADIGM-HF Investigators and Committees (2014) Angiotensin-Neprilysin inhibition versus Enalapril in heart failure. N Engl J Med 371:993–1004

Article  PubMed  Google Scholar 

Myhre PL, Vaduganathan M, Claggett B, Packer M, Desai AS, Rouleau JL, Zile MR, Swedberg K, Lefkowitz M, Shi V, McMurray JJV, Solomon SD (2019) B-type natriuretic peptide during treatment with sacubitril/valsartan: The PARADIGM-HF Trial. J Am Coll Cardiol 73:1264–1272

Article  CAS  PubMed  PubMed Central